Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial

RecruitingOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 22, 2025

Primary Completion Date

October 30, 2025

Study Completion Date

November 1, 2025

Conditions
COPDMechanical VentilationWeaning From Mechanical Ventilation
Interventions
DRUG

Doxapram

Doxapram will be given as 1.5 mg/kg will be given 10 minutes after the initiation of SBT

Trial Locations (1)

6890

RECRUITING

Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT07022704 - Doxapram Administration on Diaphragmatic Excursion in Mechanically Ventilated Patients With Chronic Obstructive Pulmonary Disease Undergoing Spontaneous Breathing Trial | Biotech Hunter | Biotech Hunter